fangchinoline has been researched along with Bone Loss, Osteoclastic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hong, G; Li, S; Liu, Q; Song, F; Tickner, J; Xu, J; Yuan, J; Zhao, J; Zhou, L | 1 |
| Dai, X; Ding, W; Shang, X; Zhu, D; Zhu, W | 1 |
2 other study(ies) available for fangchinoline and Bone Loss, Osteoclastic
| Article | Year |
|---|---|
Fangchinoline protects against bone loss in OVX mice via inhibiting osteoclast formation, bone resorption and RANKL-induced signaling.
Topics: Animals; Benzylisoquinolines; Blotting, Western; Bone Resorption; Cell Differentiation; Mice; NFATC Transcription Factors; Osteoclasts; Osteogenesis; Ovariectomy; RAW 264.7 Cells; Signal Transduction; Stephania tetrandra | 2020 |
Fangchinoline Promotes Autophagy and Inhibits Apoptosis in Osteoporotic Rats.
Topics: Animals; Apoptosis; Autophagy; Benzylisoquinolines; Bone Density; Bone Resorption; China; Disease Models, Animal; Male; Osteoblasts; Osteoporosis; Prednisolone; Rats; Rats, Wistar | 2019 |